Drug Search Results
More Filters [+]

Calmodulin

Alternative Names: calmodulin
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Calcium Binder

Novel Mechanism: Yes

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Chinese Academy of Medical Sciences
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Calmodulin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2400083281

N/A

Recruiting

Kidney Transplant

2024-10-31

CTR20202533

N/A

Not yet recruiting

Liver Cancer|Gastrointestinal Cancer

None

Recent News Events